Characteristics and prognosis of breast cancer in younger women

Journal of B.U.ON.

Volumn 14, Issue 4, 2009, Pages 619-623

  Dirier, Ahmet ^a   Burhanedtin Zincircioglu, S ^b   Karadayi, B ^b   Isikdogan, A ^b   Aksu, R ^b  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Breast cancer; Prognosis; Risk factors; Young women

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; BREAST METASTASIS; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HUMAN; LIVER METASTASIS; LOCAL METASTASIS; LUNG METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REGIONAL METASTASIS; SURVIVAL TIME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 75149132875     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Chung M, Chang HR, Bland KI, Wanebo HJ. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 1996; 77:97-103.
2. Han W, Kim SW, Park IA et al. Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BioMed Central Cancer 2004; 4:82.
3. Elkhuizen PH, van de Vijver MJ, Hermans J, Zonderland HM, van de Velde CJ, Leer JW. Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 1998; 40:859-867.
4. Colleoni M, Rotmensz N, Robertson C et al. Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 2002; 13:273-279.
5. Winchester DP, Osteen RT, Menck HR. The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer 1996; 78: 1838-1843.
6. Hartley MC, McKinley BP, Rogers EA et al. Differential expression of prognostic factors and effect on survival in young (≤ 40) breast cancer patients: a case-control study. Am Surg 2006; 72:1189-1195.
7. Sidoni A, Cavaliere A, Bellezza G, Scheibel M, Bucciarelli E. Breast cancer in young women: clinicopathological features and biological specificity. Breast 2003; 12:247-250.
8. Surveillance and End Results (SEER) Program Public-Use CD-ROM (1973-1997). National Cancer Institute, DCCPS, Cancer Surveillance Research Program, Cancer Statistics Branch, released April 2000, based on August 1999 submission.
9. Kothari AS, Fentiman IS. Breast cancer in young women. Int J Clin Pract 2002; 56 184-187.
10. El Saghir NS, Seoud M, Khalil MK et al. Effects of young age at presentation on survival in breast cancer. BioMed Central Cancer 2006; 6:194.
11. Shannon C, Smith IE. Breast cancer in adolescents and young women. Eur J Cancer 2003; 39:2632-2642.
12. Kroman N, Jensen MB, Wohlfahrt J, Mouridsen HT, Andersen PK, Melbye M. Factors influencing the effect of age on prognosis in breast cancer Population based study. BMJ 2000; 320:474-478.
13. Fowble BL, Schultz DJ, Overmoyer B et al. The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys 1994; 30:23-33.
14. Chow LW, Ho P. Hormonal receptor determination of 1,052 Chinese breast cancers. J Surg Oncol 2000; 75:172-175.
15. Tsutsui S, Ohno S, Murakami S, Hachitanda Y, Oda S. Prognostic value of c-erbB2 expression in breast cancer. J Surg Oncol 2002; 79:216-223.
16. Choi DH, Shin DB, Lee MH et al. A comparison of five immunohistochemical biomarkers and HER-2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early-onset breast carcinoma. Cancer 2003; 98:1587-1595.